Menu Search
Equities

medmix AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert
8KQ:BRN

medmix AG

Actions
  • Price (CHF)11.81
  • Today's Change0.00 / 0.00%
  • Shares traded250.00
  • 1 Year change--
  • Beta1.6915
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Medmix AG is a Switzerland-based company primarily engaged in manufacturing of healthcare, dental and beauty devices. The Company operates through two reportable segments: Healthcare along with Consumer and Industrial. Healthcare segment includes design and production of high-precision delivery devices and services within drug delivery, surgery and dental markets. Products include injection pens, surgical delivery devices focusing on trauma bone repair and wound healing tissue treatment and mixing, filling and delivery device systems for the dental consumable industry. Consumer and Industrial segment consists of design and production of high precision delivery devices within industry business unit, this includes adhesives used in construction, electronics, automotive, aerospace and various industries, and consumer markets such as beauty and other microbrush applications.

  • Revenue in CHF (TTM)468.10m
  • Net income in CHF-5.80m
  • Incorporated2021
  • Employees2.67k
  • Location
    medmix AGNeuhofstrasse 20BAAR 6340SwitzerlandCHE
  • Phone+41 417237300
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.